M.E. Reverdy

3.7k total citations · 1 hit paper
32 papers, 3.0k citations indexed

About

M.E. Reverdy is a scholar working on Infectious Diseases, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, M.E. Reverdy has authored 32 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 11 papers in Molecular Biology and 11 papers in Clinical Biochemistry. Recurrent topics in M.E. Reverdy's work include Antimicrobial Resistance in Staphylococcus (21 papers), Bacterial Identification and Susceptibility Testing (11 papers) and Bacterial biofilms and quorum sensing (10 papers). M.E. Reverdy is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (21 papers), Bacterial Identification and Susceptibility Testing (11 papers) and Bacterial biofilms and quorum sensing (10 papers). M.E. Reverdy collaborates with scholars based in France, United Kingdom and Switzerland. M.E. Reverdy's co-authors include François Vandenesch, Gérard Lina, Jérôme Étienne, Michèle Bes, Mark C. Enright, Nadia Liassine, Helen Heffernan, Timothy Greenland, Graeme R. Nimmo and Timothy S. Naimi and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Emerging infectious diseases and Intensive Care Medicine.

In The Last Decade

M.E. Reverdy

31 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Community-Acquired Methicillin-ResistantStaphylococcus aureusCarrying Panton-Valentine Leukocidin Genes: Worldwide Emergence

2003 1.4k citations François Vandenesch, Gérard Lina et al. Emerging infectious diseases profile →

Peers

Countries citing papers authored by M.E. Reverdy

Since Specialization

Citations

This map shows the geographic impact of M.E. Reverdy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.E. Reverdy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.E. Reverdy more than expected).

Fields of papers citing papers by M.E. Reverdy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.E. Reverdy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.E. Reverdy. The network helps show where M.E. Reverdy may publish in the future.

Co-authorship network of co-authors of M.E. Reverdy

This figure shows the co-authorship network connecting the top 25 collaborators of M.E. Reverdy. A scholar is included among the top collaborators of M.E. Reverdy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.E. Reverdy. M.E. Reverdy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exposure of Staphylococcus aureus to Subinhibitory Concentrations of β-Lactam Antibiotics Induces Heterogeneous Vancomycin-Intermediate Staphylococcus aureus 2014 ·Antimicrobial Agents and Chemotherapy ·Mélanie Roch, (unknown), Adriana Renzoni, M.E. Reverdy, Olivier Dauwalder, Michèle Bes, (unknown), (unknown), Frédéric Laurent, Philippe Reix, Oana Dumitrescu, François Vandenesch	33
2	MRSA HarboringmecA Variant GenemecC, France 2012 ·Emerging infectious diseases ·Frédéric Laurent, H. Chardón, Marisa Haenni, Michèle Bes, M.E. Reverdy, Jean-Yves Madec, (unknown), François Vandenesch, Anne Tristan	70
3	Staphylococcus aureus with decreased susceptibility to glycopeptides in cystic fibrosis patients 2011 ·Journal of Cystic Fibrosis ·Anne Filleron, R. Chiron, M.E. Reverdy, Hélène Jean‐Pierre, Oana Dumitrescu, (unknown), François Counil, Estelle Jumas‐Bilak, Hélène Marchandin	9
4	Utility of the Etest GRD for detecting Staphylococcus aureus with reduced susceptibility to glycopeptides in cystic fibrosis patients 2011 ·European Journal of Clinical Microbiology & Infectious Diseases ·Anne Filleron, R. Chiron, M.E. Reverdy, Hélène Jean‐Pierre, Oana Dumitrescu, (unknown), F. Counil, Estelle Jumas‐Bilak, Hélène Marchandin	1
5	Résistance aux antibiotiques chezStaphylococcus aureus 2010 ·médecine/sciences ·Oana Dumitrescu, Olivier Dauwalder, Sandrine Boisset, M.E. Reverdy, Anne Tristan, François Vandenesch	33
6	In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints 2010 ·European Journal of Clinical Microbiology & Infectious Diseases ·Christine Lascols, Pierre Legrand, Audrey Mérens, Roland Leclercq, Laurence Armand-Lefèvre, H Drugeon, Marie-Dominique Kitzis, Claudette Muller‐Serieys, M.E. Reverdy, M. Roussel‐Delvallez, Carole Ayoub Moubareck, (unknown), (unknown), (unknown), Claude–James Soussy	12
7	Optimisation des prescriptions en réanimation 2010 ·Annales Françaises d Anesthésie et de Réanimation ·J.-J. Lehot, (unknown), J. Neidecker, R Cartier, Patrick Ffrench, M.E. Reverdy, D. Revel, (unknown), (unknown), (unknown), G. Keller, G. Aulagner, (unknown)	4
8	Methicillin-resistant Staphylococcus aureus among a network of French private-sector community-based-medical laboratories 2009 ·Médecine et Maladies Infectieuses ·S. Maugat, Alexis de Rougemont, H. Aubry‐Damon, M.E. Reverdy, S. Georges, François Vandenesch, Jérôme Étienne, B. Coignard	6
9	Effect of antibiotics, alone and in combination, on Panton–Valentine leukocidin production by a Staphylococcus aureus reference strain 2008 ·Clinical Microbiology and Infection ·Oana Dumitrescu, (unknown), Michèle Bes, M.E. Reverdy, François Vandenesch, Jérôme Étienne, Gérard Lina	103
10	Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo 2007 ·British Journal of Dermatology ·F. Durupt, (unknown), Michèle Bes, M.E. Reverdy, François Vandenesch, L. Thomas, Jérôme Étienne	57
11	Sarm: Données Épidémiologiques Récentes Et Évolution De La Résistance 2005 ·Revue Francophone des Laboratoires ·Anne Tristan, G. Durand, F. Durupt, Tristan Ferry, Michèle Bes, M.E. Reverdy, H. Meugnier, François Vandenesch, Jérôme Étienne	5
12	Antibiotic prophylaxis with cefazolin and gentamicin in cardiac surgery for children less than ten kilograms 2003 ·Journal of Cardiothoracic and Vascular Anesthesia ·(unknown), M.E. Reverdy, J. Neidecker, (unknown), J Ninet, Jean-Jacques Lehot	30
13	Épidémie d'infections nosocomiales à Staphylococcus aureus résistant à la méticilline dans une maternité 2001 ·Pathologie Biologie ·(unknown), (unknown), (unknown), (unknown), (unknown), Serge Aho, (unknown), M.E. Reverdy, (unknown)	2
14	Clinical Isolate of Vancomycin-Heterointermediate Staphylococcus aureus Susceptible to Methicillin and In Vitro Selection of a Vancomycin-Resistant Derivative 2001 ·Antimicrobial Agents and Chemotherapy ·(unknown), M.E. Reverdy, (unknown), (unknown), Anne Bolmström, François Vandenesch, Jérôme Étienne	48
15	Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals 2001 ·Clinical Microbiology and Infection ·M.E. Reverdy, Sophie Jarraud, (unknown), (unknown), (unknown), Gérard Lina, François Vandenesch, Jérôme Étienne	40
16	Cinétique de bactéricidie de la PVP-I, solution dermique, sur la flore résidente du pli du coude, après application de 15 ou 30 secondes 1997 ·Médecine et Maladies Infectieuses ·M.E. Reverdy, (unknown), François‐André Allaert, Patrice Nony, J. Freney	3
17	Phenotypic and genotypic (pulsed-field gel electrophoresis) characteristics of enterotoxin-A-producing Staphylococcus aureus strains 1996 ·Research in Microbiology ·(unknown), M. Bes, Franck Renaud, Bruno Lina, M.E. Reverdy, Y Brun, J Fleurette	7
18	[Kinetics of in vitro bactericidal activity of the antiseptic biseptine combining 3 active principles]. 1996 ·PubMed ·M.E. Reverdy, M. Rougier, J Fleurette	3
19	Evolution de la sensibilité des bacilles à Gram négatif à la ceftazidime et à trois autres bêta-lactamines en milieu hospitalier de 1989 à 1993 1995 ·Médecine et Maladies Infectieuses ·A Thabaut, J Avril, Cécile Bébéar, (unknown), I. Boucot, D. Chiche, R Cluzel, Vincent Jarlier, J Grosset, J.F. Lemeland, M Meyran, H. Monteil, (unknown), M. H. Nicolas, A. Philippon, M.E. Reverdy, J. Sirot	3
20	Intestinal decontamination in a polyvalent ICU 1990 ·Intensive Care Medicine ·Jean Godard, C. Guillaumé, M.E. Reverdy, (unknown), B. Bui‐Xuan, (unknown), J Motin	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact